Meet Matthew Obinna Nwaneri, MBBS, Clinical Associate Professor of Internal Medicine.
News
Suresh Gunasekaran, MBA, currently the chief operations officer for the University of Texas Southwestern Health System in Dallas, Texas, has been selected to become the new associate vice president of University of Iowa Health Care and chief executive officer of UI Hospitals & Clinics, pending approval by the Board of Regents, State of Iowa. He is scheduled to begin at Iowa Nov. 15, 2018.
University of Iowa Hospitals & Clinics has again been named one of America’s “Best Hospitals” and the top hospital in Iowa, according to 2018-19 rankings released by U.S. News & World Report.
The youngest class member is 20, the oldest is 43. The average age of class members is 23. A total of 26% are ethnic minorities or from an under-represented group in medicine. Females make up 51 percent of the class. Read more.
University of Iowa stroke researchers have received a five-year, $1.5 million competitive grant renewal from the National Institutes of Health to continue to run a research infrastructure of 12 hospitals in Iowa, Nebraska, and North Dakota aiming to generate and efficiently perform clinical trials in acute stroke treatment, stroke prevention, and recovery.
Neuroscience graduate student Benjamin De Corte has won the Iowa Neuroscience Institute Kwak-Ferguson Fellowship for his research on the cognitive symptoms seen in disorders that disrupt the striatum in the brain.
The New York Academy of Medicine has awarded its prestigious 2018 Lewis Rudin Glaucoma Prize to Val C. Sheffield, MD, director of the Division of Medical Genetics in the UI Stead Family Department of Pediatrics, for his groundbreaking research on glaucoma treatment.
Patricia Austin, MD, a 1974 UI Carver College of Medicine graduate, has been elected president of the American Medical Association Foundation, serving a one-year term following her current year as president-elect.
The University of Iowa is expanding its role in a network of neurological research centers funded by the National Institutes of Health. The funding for NeuroNEXT, includes clinical trials for brain, nerve, and muscle disorders.
Iowa State University and the University of Iowa, have awarded seed grants to help investigators from both schools build teams, collect data, and grow projects in four general areas: antimicrobial research, vaccines and immunotherapy, brain science, and medical devices.